Following 36 months of positive results in medically administered patient case
studies on men and women, ages 30-85 and verified by physicians clinical
observations, NeuroMedica has introduced Nurenex as its first product in its
evolving Age Management Therapeutics product range for a new generation of
optimal health and wellness.
GROWTH STRATEGY
Expanding the availability of the NeuroMedica AlphaProgram marketing and
distribution alliances throughout North America and worldwide.
Establishing Age Management Therapeutics marketing alliances within existing
medical practices wishing to add the AlphaProgram to their integrative medicine
therapies.
Partnering with qualified health and wellness facilities who wish to add the
AlphaProgram to their complementary, and alternative health regimens.
Please contact us to discuss the range of dynamic and challenging opportunities
outlined above or to present other proposals you believe may be of interest to
NeuroMedica Inc.
